skip to Main Content

Welcome

Celebrating 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

Changes To E/M Codes Beginning On January 1st

Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…

read more

Additional COVID-19 Relief Up in the Air

House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin appeared to be moving closer…

read more

CY 2021 Physician Fee Schedule Proposed Rule Summary

On August 3, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

04/01/21: Fellow Exam Application Deadline
Learn more

06/01/21: Research Grant Cycle
Learn more

06/26/21: Membership Application Deadline to be eligible for AAOA Member rate for the 2021 Basic Course

08/01/21:Scientific Abstract Submission Deadline
Learn More

09/01/21: Membership Application Deadline to be voted in at the 2021 Annual Meeting

12/01/21: Research Grant Cycle
Learn more

EDUCATION

Our 2021 AAOA Basic Course in Allergy & Immunology will be launched June 1st: Over 11 hrs of pre-learning, on-demand will set you up to gain the full value of our curriculum and engage in the live-stream session.

Live Stream July 8-11 will offer unique learning formats to offer learners the core concepts of allergy diagnosis and management. Join us and test your pre-work efforts for our Immunology & Pharmacotheapy Trivia Slams; Great Debates on Environmental Controls; Allergen Testing Panel “Bake Off,” Late Night with Dr. Levy, AAOA’s Escape Room Expedition, Hands On Testing and Dose Calculation Practica, Office Tours, and more.

Structured for otolaryngologists integrating more allergy assessment and management into their practice, AAOA members providing specialized allergy care who need to remain current with literature-based evidence and practice trends, residents, PA/NPs who work in otolaryngology, and allied health staff who support their physicians in the management of allergic patients. The Basic Course offers unique opportunities to learn the state of the art in allergy patient care. Learn More

IFAR

Available Now

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2021 Basic Course in Allergy & Immunology
On-demand June 1; Live Stream July 8-11 | Virtual
Learn More and Register

USP 797 Online Module
Learn More and Register

2021 AAOA Annual Meeting
Pre-launch Mid-September
Live Stream Starting on Oct 16 | Virtual
Learn More

News and Updates

2021 AAOA Annual Meeting – Scientific Abstracts Submissions Now Open

Have novel research tied to allergy, inflammatory disease in ENT, comprehensive management of allergy and…

read more

Congress Sends Sesame Labeling Bill To President

By Beth Wang / April 15, 2021 at 11:57 AM The House on Wednesday (April 14) passed…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

AAOA Logo

Practice Resources

Clinical Care Statements

71352956 - portrait of female doctor wearing white coat in office

AAOA Clinical Care Statements 2020

Clinical Care Statements – Updated and Expanded 2020

In response to member requests, your AAOA Board of Directors adopted its original Clinical Care Statements in 2015. To help assure these statements reflect the current practice of medicine, your Board of Directors adopted this expanded and updated compendium in 2020. These statements will continue to be distributed through the AAOA Today, our membership newsletter, and posted on our website www.aaoallergy.org for easy reference for our members. Our intention is to assist otolaryngologists by sharing evidence-based summaries on recommended therapies and practices from the current medical literature. They do not attempt to define a quality of care for legal malpractice proceedings. They should not be taken as recommending for or against a particular company’s products.

The Clinical Care Statements are not meant for patients to use in treating themselves or making decisions about their care. Advances constantly occur in medicine, and some advances will doubtless occur faster than these Clinical Care Statements can be updated. Otolaryngologists will want to keep abreast of the most recent medical literature in deciding the best course for treating their patients.

This compendium of work was only achievable through the tireless efforts of our Clinical Care Statement Workgroup:

Dole Baker, MD
Douglas Dawson, MD
Charles Ebert, MD
Paul Fass, MD
Melissa Hertler, MD
Steve Houser, MD
Ayesha Khalid, MD, MBA
Adrienne Laury, MD
Stella Lee, MD
Andrea Lewis, MD
Sandra Lin, MD
Alpen Patel, MD
Matthew Patterson, MD
Glen Porter, MD
Robert Puchalski, MD
Kenneth Rodriguez, MD
Keith Sale, MD
Kristin Seiberling, MD
Farrah Siddiqui, MD
Robert Stachler, MD
Wesley VanderArk, MD
Christopher Vickery, MD
Kevin Wilson, MD
Mark Zacharek, MD

You can download and print the 2020 Clinical Care Statements Compendium as a whole or each statement individually.

TESTING

Risk Factors for Testing or Immunotherapy
Medicines to Avoid Before Allergy Skin Testing
Skin Testing Techniques for Immediate and Delayed Hypersensitivity Reaction
In Vitro Testing / Allergen-Specific IgE

IMMUNOTHERAPY

Immunotherapy Vial Preparation–Practical Considerations
Subcutaneous Immunotherapy (SCIT) for Aeroallergen Immunotherapy
Sublingual Immunotherapy (SLIT)
Vial Testing
Anaphylaxis
Anaphylaxis Crash Cart Supplies
Allergen Extract Compounding of In-Office Immunotherapy Vials/USP General Chapter <797> Compliance
Optimal Dosing
Duration of Immunotherapy
Home Subcutaneous Immunotherapy

STAFFING AND REGULATIONS

State Regulations on Staffing, Training Requirements, and AP/AH Scope of Service
Nurse Practitioners and Physician Assistants in the Practice of Allergy in the Otolaryngology Office
Available AAOA Resources

Become a Member-Join Now

As a member, you will be eligible for registration fee discounts on all AAOA CME functions and all of our patient education and practice management resources. These savings alone can offset most or all of your dues. Join Today!

Important Information

Please Note

Note:  AAOA’s Clinical Care Statements attempt to assist otolaryngic allergists by sharing summaries of recommended therapies and practices from current medical literature. They do not attempt to define a quality of care for legal malpractice proceedings. They should not be taken as recommending for or against a particular company’s products.  The Statements are not meant for patients to use in treating themselves or making decisions about their care. Advances constantly occur in medicine, and some advances will doubtless occur faster than these Statements can be updated.  Otolaryngic allergists will want to keep abreast of the most recent medical literature in deciding the best course for treating their patients.

New Blog Posts

2021 AAOA Annual Meeting – Scientific Abstracts Submissions Now Open

Have novel research tied to allergy, inflammatory disease in…

read more
Congress Sends Sesame Labeling Bill To President

By Beth Wang / April 15, 2021 at 11:57 AM The…

read more

President Mims Message

April 2017

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices. Read More

Back To Top